Atorvastatin for the prevention of chronic kidney injury in patients with chronic heart failure

Trial Profile

Atorvastatin for the prevention of chronic kidney injury in patients with chronic heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2014

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Heart failure; Renal impairment
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2014 New trial record
    • 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top